Revolutionizing Colonoscopy: Introducing VTM Technologies

This episode is dedicated to a conversation with Avishay Sidlesky, The CEO of VTM technologies, an Israeli medical device startup.

In the battle against colorectal cancer (CRC), VTM Technologies developed an innovative laser-based Virtual Tape-Measure. This new tool provides an assessment of polyp size during colonoscopy procedures, offering unparalleled accuracy and objectivity. With FDA approval already secured, VTM Technologies wishes to transform the landscape of CRC screening and surveillance.

Colonoscopy, a cornerstone of CRC prevention, holds significant importance in detecting and monitoring the disease, which ranks as the second leading cause of cancer death globally. The accuracy of follow-up colonoscopy guidelines hinges upon precise measurements of polyp size and number. Yet, current methods rely on subjective assessments by gastroenterologists, leaving room for error and potentially dire consequences for patients.

The implications of inaccuracies in polyp size assessment are profound. Overestimation may trigger unnecessarily early follow-up colonoscopies, subjecting patients to discomfort and straining healthcare resources. Conversely, underestimation poses a grave risk, delaying cancer diagnosis and compromising survival rates.

VTM Technologies' system addresses these critical challenges head-on. By providing objective measurements, it eliminates the pitfalls of subjective assessment, promising to save lives and reduce healthcare costs.

As VTM Technologies embarks on its journey to commercialize the new device, it seeks strategic partnerships and investment to propel its mission forward.

#TheHealthcareStage #Colonoscopy #coloncancer #VTMtechnologies

The podcast is also available on YouTube at The Healthcare Stage YouTube channel

https://www.youtube.com/@TheHealthcareStage